Earnings History Data for Arcellx (ACLX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Arcellx
Arcellx Inc. is a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx Inc. is based in GAITHERSBURG, Md.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
07-11-2024 | PM | ACLX | Arcellx | 4,683 | -0.48 | -0.54 | 0.00 | Arcellx GAAP EPS of -$0.48, revenue of $26.03M [11/8/2024 6:16 AM] |
103.33 | 4.17 (4.21%) |
99.16 | 0.0 (0.00%) |
43.50 - 106.24 | 744,744 | 750,000 | 2,518 | ||
|
||||||||||||||||||
08-08-2024 | PM | ACLX | Arcellx | 2,768 | -0.51 | -0.54 | 0.00 | Arcellx GAAP EPS of -$0.51, revenue of $27.38M [8/9/2024 6:21 AM] |
59.10 | 6.52 (12.40%) |
52.58 | 0.0 (0.00%) |
30.88 - 75.10 | 696,679 | 430,000 | 15,610 | ||
09-05-2024 | PM | ACLX | Arcellx | 2,793 | -0.14 | -0.51 | 0.00 | Arcellx GAAP EPS of -$0.14, revenue of $39.3M [5/10/2024 7:10 AM] |
49.75 | -2.98 (-5.65%) |
52.73 | 0.0 (0.00%) |
30.74 - 75.10 | 773,261 | 400,000 | 24,727 | ||
28-02-2024 | AH | ACLX | Arcellx | 3,130 | 0.42 | -0.63 | 0.00 | Arcellx reports Q4 results [2/28/2024 5:19 PM] |
65.79 | -1.53 (-2.27%) |
68.48 | 1.16 (1.72%) |
26.32 - 70.05 | 435,710 | 370,000 | 5,116 | ||
13-11-2023 | PM | ACLX | Arcellx, Inc. | 2,150 | -0.81 | -0.42 | -0.68 | Arcellx GAAP EPS of -$0.81 misses by $0.12, revenue of $14.96M beats by $2.37M [11/14/2023 1:59 AM] |
47.25 | 1.75 (3.85%) |
45.50 | 0.0 (0.00%) |
18.70 - 48.92 | 590,388 | 1,090,000 | 9,924 | ||
14-08-2023 | AH | ACLX | Arcellx | 1,631 | -0.50 | -0.68 | 0.00 | Arcellx GAAP EPS of -$0.50, revenue of $14.3M [8/14/2023 5:20 PM] |
35.82 | 2.14 (6.35%) |
37.50 | 3.82 (11.34%) |
15.63 - 48.92 | 1,684,243 | 380,000 | 4,046 | ||
08-05-2023 | AH | 4:00 PM ET (May 8) |
ACLX | Arcellx | 2,070 | -0.58 | 2.52 | 0.00 | Arcellx GAAP EPS of -$0.58, revenue of $17.91M [5/8/2023 5:05 PM] |
44.71 | 1.48 (3.42%) |
42.93 | -0.30 (-0.69%) |
6.03 - 45.05 | 373,849 | 550,000 | 8,884 | |
14-11-2022 | PM | ACLX | Arcellx | 987.00 | -0.68 | -0.93 | 0.00 | Arcellx GAAP EPS of -$2.12 [11/15/2022 9:42 AM] |
21.76 | 0.17 (0.79%) |
21.59 | 0.0 (0.00%) |
6.03 - 26.91 | 685,738 | 480,000 | 17,449 | ||
|
||||||||||||||||||
15-08-2022 | AH | ACLX | Arcellx | 830.00 | -0.88 | -1.20 | 0.00 | Arcellx GAAP EPS of -$0.88 [8/15/2022 5:37 PM] |
20.14 | 0.90 (4.68%) |
19.24 | 0.0 (0.00%) |
6.04 - 26.91 | 1,063,614 | 380,000 | 610 | ||
12-05-2022 | AH | ACLX | Arcellx, Inc. | 346.00 | -1.56 | -0.95 | 0.00 | Arcellx GAAP EPS of -$1.56 misses by $0.46 [5/12/2022 5:05 PM] |
8.97 | 0.18 (1.99%) |
8.80 | 0.0 (0.00%) |
8.07 - 19.93 | 50,973 | 70,000 | 211 | ||